Failure to stimulate antibodies in man after 7 days' high-dose treatment with rifampicin.
D000906:Antibodies / Q000032:analysis*; D004338:Drug Combinations / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology; D004342:Drug Hypersensitivity / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*; D014295:Trimethoprim / Q000008:administration & dosage / Q000009:adverse effects / Q000276:immunology*
D000906:Antibodies; D004338:Drug Combinations; C020800:Rifaprim; D014295:Trimethoprim; D012293:Rifampin